N-Terphenylpicolinamide derivatives designed to target PD-L1 increase activation and proliferation of T cells, and their cytotoxic properties toward cancer cellsEuropean Journal of Medicinal ChemistryIF5.92026-02-060PRE
Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein (vol 27, 8282, 2022)MOLECULESIF4.62024-06-200OAAI
C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein-Protein InteractionMOLECULESIF4.62024-06-041OAAI
Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for m-Terphenyl DerivativesACS MEDICINAL CHEMISTRY LETTERSIF42023-12-145OAAI
Discovery of Inhibitory Fragments That Selectively Target Spire2-FMN2 InteractionJOURNAL OF MEDICINAL CHEMISTRYIF6.82023-12-010OAAI
Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 ProteinMOLECULESIF4.62022-11-281OAAI
Exploring the Surface of the Ectodomain of the PD-L1 Immune Checkpoint with Small-Molecule FragmentsACS CHEMICAL BIOLOGYIF3.82022-09-0812OAAI
Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 InteractionMOLECULESIF4.62022-05-274OAAI
Terphenyl-Based Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein InteractionJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-07-2751OAAI
Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 AntagonistsACS MEDICINAL CHEMISTRY LETTERSIF42021-04-2839OAAI
Multicomponent Peptide Stapling as a Diversity-Driven Tool for the Development of Inhibitors of Protein-Protein InteractionsANGEWANDTE CHEMIE-INTERNATIONAL EDITIONIF16.92020-02-0635OAAI
Hitting on the move: Targeting intrinsically disordered protein states of the MDM2-p53 interactionEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92019-11-0110OAAI
The synthesis and characterization of tetramic acid derivatives as Mdm2-p53 inhibitorsJOURNAL OF MOLECULAR STRUCTUREIF4.72019-08-012PREAI
A therapeutic patent overview of MDM2/X-targeted therapies (2014-2018)EXPERT OPINION ON THERAPEUTIC PATENTSIF4.62019-03-0131OAAI
A fluorinated indole-based MDM2 antagonist selectively inhibits the growth of p53wt osteosarcoma cellsFEBS JOURNALIF4.22019-02-1611OAAI
Rational design and synthesis of 1,5-disubstituted tetrazoles as potent inhibitors of the MDM2-p53 interactionEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92017-01-0140OAAI
A Unique Mdm2-Binding Mode of the 3-Pyrrolin-2-one- and 2-Furanone-Based Antagonists of the p53-Mdm2 InteractionACS CHEMICAL BIOLOGYIF3.82016-10-1733OAAI